Tumor markers in patients with non-seminomatous germ cell tumors of the testis

P. H. Willemse, D. T. Sleijfer, H. Schraffordt Koops, H. W. De Bruijn, J. W. Oosterhuis, T. M. Brouwers, T. Ockhuizen, J. Marrink

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

24 Citaten (Scopus)


In 82 patients with non-seminomatous germ cell tumors, the levels of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and lactate dehydrogenase (LDH) were determined to find if there was a relation to clinical stage. Only two out of 34 patients could be restaged as a result of the presence of elevated marker levels. Markers were present in 12% of patients with stage IIA, 67% with stage IIB amd 85% with stage III. In contrast to HCG, the initial levels of LDH and AFP were related to tumor stage. A return of marker levels to normal during chemotherapy always meant tumor regression and incidated complete remission in 42% of patients. Initial marker levels did not correlate with the eventual destruction of all tumor by chemotherapy. A rise in marker levels always correlated with tumor progression. In conclusion, tumor markers have only a limited value in clinical staging. Disappearance of markers during chemotherapy does not always indicate destruction of all viable tumor, probably because non-producing cell lines such as mature teratoma may persist after chemotherapy.

Originele taal-2Engels
Pagina's (van-tot)117-128
Aantal pagina's12
TijdschriftOncodevelopmental Biology and Medicine
Nummer van het tijdschrift1-2
StatusGepubliceerd - 1981


Duik in de onderzoeksthema's van 'Tumor markers in patients with non-seminomatous germ cell tumors of the testis'. Samen vormen ze een unieke vingerafdruk.

Citeer dit